Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Reuters May 29, 2020 16:47:10 IST
Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Bengaluru: Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.

"Nafamostat (has been) identified as a potential candidate for COVID-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany," the company said in a statement.

Click here to follow LIVE updates on coronavirus outbreak

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Updated Date:

also read

COVID-19 update: India reports 2,841 new cases, nine deaths in last 24 hours, active cases dip to 18,604
India

COVID-19 update: India reports 2,841 new cases, nine deaths in last 24 hours, active cases dip to 18,604

The fresh COVID-19 infections reported on Friday were marginally higher than 2,827 cases logged on Thursday. The daily positivity rate was recorded at 0.58 per cent, while the weekly positivity rate was 0.69 per cent

India logs 2,202 new COVID-19 cases in last 24 hours, down 11.45% from day ago; daily positivity rate up at 0.74%
India

India logs 2,202 new COVID-19 cases in last 24 hours, down 11.45% from day ago; daily positivity rate up at 0.74%

India now has 17,317 active cases of COVID-19, a decline of 375 cases in the active caseload in a span of 24 hours. The active cases now comprise of 0.04 per cent of the total infections

COVID-19: 393 new cases, 2 more deaths in Delhi, positivity rate 3.35 %
Health

COVID-19: 393 new cases, 2 more deaths in Delhi, positivity rate 3.35 %

Delhi had reported 377 new Covid cases and one more death on Monday, while the positivity rate was 3.37 percent